Nasal fractional exhaled nitric oxide analysis with a novel hand-held device.
OBJECTIVE
To assess the performance of a novel hand-held nitric oxide (NO) analyzer in the measurement of nasal fractional exhaled NO (FE(NO)).


METHODS
In ten healthy subjects (controls) and ten patients with chronic rhinosinusitis (CRS), oral and nasal FENO were obtained with the NIOX MINO Airway Inflammation Monitor (Aerocrine AB, Solna, Sweden) on two consecutive days, complying with current standards.


RESULTS
Intraclass correlation coefficient (ICC) of oral FENO was 0.91 and of nasal FE(NO) 0.79. In controls, mean (+/- SD) nasal FENO (40.3 +/- 23.6 ppb) was higher than oral FENO (15.6 +/- 2.7 ppb; p = 0.005). In CRS patients, mean oral FENO (23.9 +/- 12.2 ppb) was higher than in controls (15.6 +/- 2.7 ppb; p = 0.01). CRS patients with nasal polyps had lower nasal FE(NO) levels (19.7 +/- 5.9) than healthy controls (40.3 +/- 23.6 ppb; p = 0.01).


CONCLUSIONS
The novel hand-held NO analyzer was found suitable for nasal FE(NO) measurements. It may be useful in differentiating hyperplasic eosinophil rhinosinusitis from chronic unspecific rhinosinusitis. Moreover, nasal FE(NO) may be used to monitor the clinical course of CRS with polyps.
Weschta
Michael
M
Department of Otorhinolaryngology & Head and Neck Surgery, University Hospital of Ulm, Germany.
Deutschle
Tom
T
Riechelmann
Herbert
H
D000328:Adult; D001944:Breath Tests / Q000295:instrumentation* / Q000379:methods; D002908:Chronic Disease; D004867:Equipment Design / Q000639:trends; D045853:Exhalation; D005260:Female; D006801:Humans; D008297:Male; D009569:Nitric Oxide / Q000032:analysis*; D010865:Pilot Projects; D015203:Reproducibility of Results; D012220:Rhinitis / Q000175:diagnosis; D012680:Sensitivity and Specificity; D012852:Sinusitis / Q000175:diagnosis
D009569:Nitric Oxide